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ABSTRACT: Galectins are a family of low molecular weight β-
galactoside binding proteins with functions in cell growth, cell 
activation, cell–cell, cell–matrix adhesion including binding to 
carcinoembryonic antigen, laminin and metalloprotenase. Higher 
endogenous expression of Galecin-3 (Gal3) and Galectn-1(Gal-1) has 
been found in malignancies. Several other galactose specific lectin 
binding patterns have been reported to differentiate dysplastic 
epithelium from normal epithelium. Galectin expression studies in 
cervical epithelium are comparatively less. We analyzed the 
endogenous expression of Gal-1, Gal-3 and the binding profile of a 
plant lectin with identical sugar specificity in cervical intra epithelial 
neoplasia (CIN) to evaluate its significance as a marker to assess the 
malignant potential of CIN. Sections from 66 archival samples of 
colpscopic biopsy were analyzed using the standard 
immunohistochemical method using polyclonal antigalectin 
antibodies and HRP conjugated snake gourd lectin using DAB as the 
chromogen. The expression pattern was assessed semi 
quantitatively and analysed statistically to see the significance as a 
predictor of the malignant potential of CIN. Galectin expression was 
observed in cytoplasm and cell membrane. Neither the galectins nor 
the plant lectin seemed to have any role in predicting malignant 
potential if cervical intra epithelial lesion. As these lectins express 
more in differentiated epithelium this can be suggested as markers 
of differentiation which may have some significance in tumor 
pathology.  
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Introduction 
Cancer of the uterine cervix is the second most common cancers 
among women worldwide. It accounts for 15% of all cancers 
diagnosed among women. Nearly 20% of these cancers occur in 
developed countries and 80% in developing countries. In India, 
according to the data available from population based cancer 
registries at Banglore, Madrass and Bombay, the crude incidence 
rates are 39.7, 46.5 and 15.4 per 100,000 females respectively [1]. 
Invasive cervical carcinoma is preceded by a spectrum of 
heterogeneous epithelial changes called pre-cancerous lesions or 
dysplasia or cervical intra epithelial neoplasia (CIN) [2]. These pre- 
invasive lesions usually develops through several grades namely 
mild, moderate and severe dysplasia or CIN I, II and III or SIL 
(Squamous Intra epithelial Lesion) low and high grades, which may 
lead to invasive cancer over a period of time, if left untreated. The 
rate of progression of these lesions to cancer has been reported to 
vary from 4.4% to 65% depending upon the severity of the lesion. 
Studies have demonstrated progress from CIS (Carcinoma Insitu) to 
invasive carcinoma to range from 25-70% [2]. In the British 
Columbia cohort study, for cohort I, 61% of the cases of CIS were 
estimated to be regressed during the age of 40-60 years. For cohort 
II, the regression rates were 70% over the age of 25-44 years and 
77% over the age of 20-39 years. Murthy has found a relative risk of 
developing CIS in various grades of dysplasia to be 5.1, 3.73 and 
114.4 respectively for mild, moderate and severe dysplasia [3] 
Among the 1107 dysplasia patients followed up, 64 (5.8%) revealed 
malignancy at the first follow up within three months of initial 
recruitment, while another 79% developed malignancy during 
subsequent years. It was 0.66 for mild, 5.0 for moderate and 16.1 
per 100 women years for severe dysplasia [3]. The role of Human 
Papilloma Virus in the development of early CIN has been 
established. HPV type 16, 18 and others has been reported to 
involve in the etiology of at least 90% of the Indian cervical cancers. 
It has been reported that HPV infection alone cannot be considered 
as predisposing factor for CIN and a considerable number of CIN 
cases will revert to normal or remain as such without progressing to 
invasive carcinoma [2]. If biological markers can accurately predict 
the CIN lesions which have more chance to progress to higher up 
lesions, treatment and further cytological follow up can be limited to 
them alone instead of managing all the dysplasias. Interest has 
therefore been focused to identify markers to identify high risk the 
CIN cases which have the potential to progress to invasive 
carcinoma and that can be used as a pre-selection criterion for 
further management. Studies on oral premalignant lesions exhibiting 
epithelial dysplasia have shown changes in the glycosylation pattern, 
where as such changes are only occasionally seen in lesions without 
dysplasia [5,6]. Lectins are reported to be useful in identifying these 
changes in the glycosylation pattern. The present study analyzed the 
pattern of expression of endogenous lectins, galectin-1, galectin-3 
and a galactose specific plant lectin, Snake gourd lectin-(SGL) 
binding pattern in normal, different grades of CIN and malignant 
tissues of cervix to see whether the SGL binding pattern or the 
galectin expression show any significant difference between 
different grades of dysplasia and malignancy so that galectose 
specific ligand study can be used to preselect high risk cervical intra 
epithelial lesions. 
 
Materials and Methods  
Lectin from the seeds of snake gourd was isolated, purified and 
conjugated to horseradish peroxidase type IV according to the 
technique described elsewhere [6,7] In short, the lectin isolated 
from the seeds by ammonium sulphate fractionation was purified by 
affinity chromatography on cross-linked guar gum. The molecular 
weight of the lectin was found out by gel filtration on sephadex G-
100 (Sigma chemical company). The purity of the lectin was 
confirmed on electrophoretic analysis. The purified lectin was 
conjugated to horseradish peroxidase type IV. Polyclonal antigalectin 
antibodies of Gal-1 and Gal-3 were purchased from Novocastra.   
Sections from archival blocks of colposcopy directed punch biopsy 
specimens were used for this study. Normal cervical tissues were 
obtained from hysterectomy specimens. A total of 66 samples were 
analyzed, which includes normal (12), CIN I (11), CIN II (10), CIN, 
III (10), Invasive squamous cell carcinoma (16) and 
adenocarcinoma (7) cases. Representative sections were selected by 
correlating with the original H&E sections used for the initial 
diagnosis. Standard immunohistochmical method was followed using 
DAB as the chromogen. The sections were incubated with primary 
antibodies / SGL at 4°C for one hour. Anti galectin antibodies were 
used in a concentration of 1:100 dilutions and the SGL was used in a 
concentration of 0.06 µ /ml. Negative controls were included for 
each batch. The extent of specifically bound markers was stained in 
30% 3’-3’diaminobenzedene containing hydrogen peroxide for 3-5 
minutes. The sections were then counterstained with 
haematoxylene. The intensity of the lectin binding was assessed on 
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a 0-3+ scale in different levels of maturation of the cervical 
epithelium in the different grades of cervical intra epithelial 
neoplasia and in malignancies. The percentage of cells with each 
grades of lectin binding patterns were assessed. The mean score 
along with standard deviation, standard error mean and 95% 
confidence interval for each levels of epithelium in normal and in 
different grades of CIN were statistically analyzed giving specific 
values 1,2 and 3 for +, ++, and +++ respectively. Malignancies 
were exempted from the analysis owing to the uniform pattern of 
expression. 
 
Results 
Galectin-3 and galectin-1 expressions were observed in all of the 
normal, all grades of CIN and in malignancies. The expression 
pattern of galectins as mean score for each levels of epithelium is 
given in table I. The expression pattern for both the galectins were 
found to vary in different maturation levels of the epithelium (Fig I). 
The most mature superficial layers of all the samples showed 
expression of both of the galectins with a mean score of 1.5 for gal-
1 and 1.6 for gal-3. Whereas, expression of both the gal-3 as well as 
gal-1 was found to decrease towards the deeper immature layers. 
The mean value for gal-3 and for gal-1 in the mid zone were 0.67 
and 0.83, whereas it was 0.50 and 0.67 in the basal zone. For CIN I 
as well as CIN II, the pattern of expression of both the galectins was 
more or less similar to that of normal epithelium (Fig II). Higher 
expressions were confined to the differentiated layers only. The 
mean score for gal-3 and gal-1 were 1.55, 1.30 & 1.09, 1.50 with 
95% confidence intervals of 0.99 - 2.10, 0.95 - 1.65 & 0.62 - 1.5, 
1.12 - 1.88 for superficial layer in CIN I & II whereas, it was1 & 
0.91, 1.30 with 95% confidence interval of 0.42 - 1.52, 0.66 - 1.34 
and 0.35 - 1.47, 0.95 - 1.65 for mid zone.  The basal zones showed 
the mean values as 0.45, 0.50 and 0.73, 0.70 respectively.  No 
significant difference was observed between normal and dysplastic 
epithelium except for severe dysplasia, which showed a mean value 
of 1 and 0.9 for gal-3 and gal-1 for the basal layer also. In 
malignancies, the expressions were higher for both of the galectins 
and was found to increase with differentiation uniformly in all cases 
of Squamous cell carcinomas (Fig III). As no difference was 
observed in the expression pattern between individual samples of 
squamous cell carcinomas, malignancies were exempted from 
statistical analysis. The adenocarcinomas also showed uniform 
expression pattern for both the galectins. The expression of both 
gal-3 as well as gal-1 were diffuse, uniform and cytoplasmic. No 
nuclear expressions were observed. Normal endocervical cells 
showed apical luminal expression for both the galectins (Fig I). In 
adenocarcinomas also the expression was luminal (Fig III). 
Moderate expressions were observed for koilocytes also.
 
Table I   Univariate analysis of Galectin expression pattern in Cervical Epithelium 
 Mean Standard deviation Standard error 
mean 
95 %CI 
  
Gal-3  
 
 
Gal-1 
 
Gal-3 
 
Gal-1 
 
Gal-3 
 
Gal-1 
Gal-3 Gal-1 Gal-3 Gal-1 
Normal 
Super 
mid 
basal 
 
1.67 
0.67 
0.50 
 
1.5 
0.83 
0.67 
 
0.267 
0.52 
1.22 
 
0.55 
0.41 
0.52 
 
0.21 
0.21 
0.5 
 
0.22 
0.17 
0.21 
 
1.22 
0.12 
0.79 
 
2.21 
1.21 
1.79 
 
0.93 
0.40 
0.12 
 
2.07 
1.26 
1.21 
Sq. met 
Super 
mid 
basal 
 
1.17 
0.83 
0.83 
 
1.5 
1.17 
1 
 
0.41 
0.41 
1.17 
 
0.84 
0.97 
1.10 
 
0.17 
0.17 
0.48 
 
0.34 
0.40 
0.45 
 
0.74 
0.40 
0.34 
 
1.60 
1.26 
2.06 
 
0.62 
0.13 
-0.15 
 
2.38 
2.20 
1.21 
CIN 1 
Super 
mid 
basal 
 
1.55 
1 
0.45 
 
1.09 
0.91 
0.73 
 
0.82 
0.77 
0.873 
 
0.70 
0.83 
1.19 
 
0.25 
0.23 
0.28 
 
0.21 
0.25 
0.36 
 
0.99 
0.42 
-0.7 
 
2.10 
1.52 
1.18 
 
0.62 
0.35 
-7.18 
 
1.56 
1.47 
1.53 
CIN 2 
Super 
mid 
basal 
 
1.30 
1 
0.50 
 
1.50 
1.30 
0.70 
 
0.48 
0.22 
0.53 
 
0.53 
0.48 
0.67 
 
0.15 
0.15 
0.17 
 
0.17 
0.15 
0.21 
 
0.95 
0.66 
-.17 
 
1.65 
1.34 
1.08 
 
1.12 
0.95 
0.22 
 
1.88 
1.65 
1.18 
CIN3 
Super 
mid 
basal 
 
1.20 
0.1 
1 
 
1.30 
0.10 
0.90 
 
0.42 
0.32 
0.77 
 
0.67 
0.32 
0.83 
 
0.13 
1 
0.23 
 
0.21 
1 
0.25 
 
0.90 
-.13 
0.42 
 
1.50 
0.33 
1.52 
 
0.82 
-0.13 
0.35 
 
1.78 
0.33 
1.47 
 
Table II  Univariate analysis of SGL binding pattern in cervical epithelium 
 
 
 
Mean 
Standard deviation Standard 
error mean 
 
95% CI 
 
Normal 
Superficial 
Mid 
Basal 
 
1.28 
0.57 
0.50 
 
0.41 
0.52 
0.50 
 
0.20 
0.21 
0.20 
 
0.74 
0.12 
0.10 
 
1.50 
1.21 
1.20 
Sq. Metaplasia 
Superfical 
Mid 
Basal 
 
1.1 
0.67 
0.50 
 
0.41 
0.52 
0.55 
 
0.17 
0.21 
0.22 
 
0.74 
0.12 
-7.48 
 
1.60 
1.21 
1.07 
CIN 1 
Superficial 
Mid 
Basal 
 
1.09 
1 
0.64 
 
0.54 
0.45 
0.50 
 
0.16 
0.13 
0.15 
 
0.73 
0.70 
0.30 
 
1.45 
1.30 
0.98 
CIN 2 
Superficial 
Mid 
Basal 
 
1.20 
0.70 
0.68 
 
0.42 
0.67 
0.47 
 
0.13 
0.21 
0.19 
 
0.90 
0.22 
0.32 
 
1.50 
1.18 
0.93 
CIN3 
Superficial 
Mid 
Basal 
 
1.10 
0.60 
1 
 
0.57 
0.70 
0.67 
 
0.18 
0.22 
0.21 
 
0.69 
0.98 
0.52 
 
1.51 
1.10 
1.48 
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SGL binding was also similar to the galectin expression pattern. The 
mean score for each level of tissue layers is given in the table I. The 
mature superficial layer showed a higher binding pattern with a 
mean value of 1.28. The binding intensity in the lower layers was 
comparatively lesser(Fig I). The mean value for the mid zone and 
the basal zone were 0.57 and 0.50 for normal epithelium. No 
significant difference in binding pattern was observed between 
different grades of dysplasias (Fig II). In CIN I, II and III the 
intensity of SGL biding were higher in differentiated layers with a 
mean value of1.09, 1.20 and 1.10 for CIN I, II and III respectively 
with 95% confidence intervals of 0.73-1.45, 0.90-1.50 and 0.69-
1.57 respectively. The binding patterns found to decrease towards 
the deeper layers except in CIN III, for which the basal layer also 
showed a mean value of 1. Similar to galectin expression the 
binding was mainly cytoplasmic and the pattern was diffuse 
uniform. In squamous metaplasia also the differentiated layer 
showed moderate expression of galectins and moderate SGL 
binding. Similarly the koilocytes also showed SGL binding in 
moderate grade (Fig III). Unlike the galectins the normal 
endocervical cells showed diffuse uniform cytoplasmic binding. In 
squamous cell carcinomas, similar to galectins the SGL binding was 
higher in differentiated areas. But in adenocarcinomas the binding 
was different from galectins, as SGL showed uniform binding all 
over the cytoplasm (Fig III).
 
Fig I Expression patterns of Gal-3,Gal-1 and SGL binding in normal, metaplastic and endocervical epithelium of the uterine cervix 
Fig A. Higher (++) diffuse cytoplasmic expression of Gal-3 in the superficial 
layers of Squamous epithelium (40 X) 
B. Higher (++) diffuse cytoplasmic expression of Gal-1 in the superficial 
layers of Squamous epithelium (40 X) 
C. Higher (++) diffuse cytoplasmic binding of SGL in the superficial 
layer of Squamous epithelium (40 X) 
D. Higher (++) diffuse cytoplasmic expression of Gal-3 in differentiated 
layers of Metaplastic epithelium (40 X) 
E. Higher (++) diffuse cytoplasmic expression of Gal-1in differentiated 
layers of Metaplastic epithelium (40 X) 
F. Higher (++) diffuse cytoplasmic binding of SGL in differentiated 
layers of Metaplastic epithelium 
G. Luminal expression of Gal-3 in the normal mucus secreting endocervical 
cells (40X) 
H. Luminal expression of Gal-1 in the normal mucus secreting endocervical 
cells (40X) 
I.  Uniform diffuse binding of SGL in the normal mucus secreting endocervical 
cells (40X). 
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Fig II Expression patterns of Gal-3,Gal-1 and SGL binding in CIN I,CIN II and CIN III. 
Fig A. Higher (++) diffuse cytoplasmic expression of Gal-3 in the differentiated layers in CIN I (40 X) 
B. Higher (++) diffuse cytoplasmic expression of Gal- in the differentiated layers in CIN I (40 X) 
C. Higher (++) diffuse cytoplasmic binding of SGL in differentiated layers in 
CIN I (40 X) 
D. Higher (++) diffuse cytoplasmic expression of Gal-3in the differentiated layers inCIN II (40 X) 
E. Higher (++) diffuse cytoplasmic expression of Gal-1 in the differentiated  layers inCIN II (40 X) 
F. Higher (++) diffuse cytoplasmic binding of SGL the differentiated layers in CIN II 
G. Higher (++) diffuse cytoplasmic expression of Gal-3 in the differentiated  layers and mild (+) expression in the basal layer in CIN III (40X) 
H. Higher (++) diffuse cytoplasmic expression of Gal-1 in the differentiated  layers and mild (+) expression in the basal layer in CIN III (40X) 
I Higher (++) diffuse cytoplasmic binding of SGL in the differentiated layers and  mild (+) binding in the basal layer in CIN III (40X) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig III Expression patterns of Gal-3,Gal-1 and SGL binding in Squamous cell carcinoma, Adenocarcinoma and Koilocytes of the Uterine Cervix. 
 
Fig A. Higher diffuse expression of Gal-3 in the differentiated layers of quamous cell Carcinoma (10X) 
 B. Higher diffuse expression of Gal-1 in the differentiated layers of Squamous cell Carcinoma (10X) 
 C. Higher diffuse binding of SGL in the differentiated layers of Squamous cell Carcinoma (10X) 
 D. Luminal expression of Gal-3 in adenocarcinoma (40 X). 
 E. Luminal expression of Gal-1 in adenocarcinoma (40 X). 
 F. Diffuse uniform binding of SGL in adenocarcinoma (40X) 
 G. Moderate expression of Gal-3 in Koilocytes (40X). 
 H. Moderate expression of Gal-1 in Koilocytes (40X) 
 I. Moderate binding of SGL in Koilocytes (40X) 
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Discussion 
Cancer of the uterine cervix is characterized by a series of 
progressive pre-malignant changes ranging from CIN I to CIN III. In 
developed countries, this disease has been effectively controlled by 
the introduction of mass screening programms with the “Pap smear” 
test. The efficacy of “Pap smear” in detecting cancers and pre 
cancerous lesions of cervix has been much improved by the 
introduction of quality control measures [8].  However, in India and 
in several other developing countries, the infra structure for 
screening programmes and opportunity for diagnostic work up and 
treatment may not be sufficient for screening all women. If the high-
risk precancerous lesions can be identified from the cytologically 
detected CIN cases, treatment can be limited to this pre-selected 
group alone and the disease can be controlled in a much better cost 
effective way.  
There are several reports demonstrating different lectin binding 
pattern for dysplasias and malignancies of the uterine cervix and 
oral mucosa [9,10]. JFL has been reported as a good marker of 
differentiating pre-cancerous lesions in cervical epithelium [11-13]. 
They have studied the JFL specific glycoconjugates expression 
during the progression of cervical intra epithelial neoplasia in 
exfoliated cells.  They found that only mild grade of JFL binding in 
non-neoplastic cells and the binding was reported to increase with 
increase of cytological atypia. Also they have reported a higher 
binding pattern associated with squamous differentiation of cells. 
Normal endocervical cells were reported to show higher lectin 
binding whereas the metaplastic cells showed a reduction in binding 
and mild grade of JFL binding had a negative correlation and 
intense grade of staining had a positive correlation with the stage of 
the tumor. Naik [14] have studied the binding pattern of a panel 
of16 lectins in different grades of vulvar intra epithelial neoplasia 
(VIN), metastasizing and non-metastasizing squamous carcinomas 
and have correlated the binding pattern with metastatic potential 
and other clinical / tumor characteristics. They found no difference 
in lectin binding pattern between the different histological subtypes 
of VIN and no consistent difference they observed between 
metastasizing and non metastasizing primary tumors, also no 
difference in staining pattern between nodal metastasis and the 
corresponding primary tumor. They observed no identifiable 
correlation between lectin binding pattern and subsequent survival 
or local or regional recurrence. The same groups have analyzed the 
lectin binding pattern in the vulvar normal squamous epithelium and 
epithelium adjacent to VIN and squamous cell carcinoma in another 
study [14]. They found no alteration to lectin binding pattern in 
normal vulvar epithelium with respect to patient’s age, menstrual 
status, estrogen therapy or history of VIN. Lectins, MPA and LCA 
were identified as markers of cellular differentiation and maturation. 
T antigen as shown by the lectin PNA was almost universally 
present in histologically normal epithelium adjacent to VIN and 
vulvar tumors, contrasting with the lack of PNA binding in normal  
vulvar epithelium, a finding suggestive of a local field change 
surrounding pre-invasive and invasive vulvar lesion, the tumor 
tissue was observed with a moderate intensity. In the present 
study, normal and dysplastic epithelium showed moderate binding 
of SGL in the differentiated superficial layer only. The immature 
basal layer didn’t show any binding in normal as well as in 
dysplasias. The metaplastic epithelium also exhibited the same 
binding pattern suggesting the SGL binding pattern as a marker of 
differentiation rather than the malignant potential of the 
preneoplastic lesions. In malignancies also the intensity of 
expression was higher (++) in differentiated areas, whereas the 
undifferentiated areas showed mild grade (+) of binding only. The 
difference in SGL binding pattern may be due to the alteration of 
cell surface glycoconjugates during the malignant transformation 
which is not recognized in the early neoplastic changes. However, 
SGL recognizes these changes in high-grade intraepithelial lesions 
as evident in the SGL binding pattern of the severe dysplastic 
lesions.  As all the severe dysplastic lesions showed the same 
pattern of binding no pre-selection among these severe dysplasia 
group could be suggested using SGL binding pattern. Thus, the 
present study didn’t suggest any role for SGL in predicting the 
malignant potential of CIN and supports the report of Naik in the 
application of plant lectins in VIN.  
Galectins are a family of low molecular weight β-galactoside specific 
lectins with functions in cell growth, cell activation, cell–cell, cell–
matrix adhesion including binding to carcinoembryonic antigen, 
laminin and metalloproteinase [2]. Gal-3 and Gal-1 have been found 
to enhance metastatic potential of human tumors by interacting with 
T antigen in a number of experimental studies [15-19]. Galectin 
expression studies in cervical epithelium are comparatively less. To 
our knowledge this is the first report. However galectin expression 
studies in squamous cell carcinoma of oropharynx and larynx has 
been reported [20]. Expression of galectin-3 was confined only to 
areas of high levels of keratinization in moderately/ highly 
differentiated carcinomas. No gal-3 expression was observed in the 
basal layers of cells studied in normal epithelium. The supra basal 
layers were positive in epidermis, epithelium of tongue and cornea 
and negative in the epithelium of palatine tonsil [20]. In another 
study of the squamous cell carcinoma and normal epithelium of 
tongue it has been reported that nuclear expression of galectin-3 
markedly decreased during the progression from normal to cancer 
state while cytoplasmic expression increased [21]. Enhanced 
expression of galectin-3 in the cytoplasm has been reported to 
associate with reduced disease free survival of tongue cancer 
patients [17]. In the present study also the expression of galectins 
were confined to differentiated cell layers only in the normal and 
dysplastic epithelium. A similar observation has been reported in the 
squamous epithelium of oropharyngial region and larynx suggesting 
its correlation with the extent of differentiation [20]. In malignancies 
the galectin-1 as well as galectin3 was found to show higher 
expression in the differentiated areas uniformly in the entire 
squamous cell carinomas studied.  Higher expression patterns were 
observed in keratinising areas of squamous cell carcinomas as 
observed by Plazak. In adenocarcinomas, the expression for both 
the galectins were uniform in all the cases. Also the present study 
didn’t observe any nuclear expression of galectins in any of the 
lesions analyzed. Expression of galectins particularly galectin-3 has 
been reported associate with progression of invasive tumors [22-
25]. The molecular mechanism of this correlation has been proposed 
to be the inter action of galectin with Poly –N-actyl-lactosamines on 
laminin which may help in cellular invasion. The present study 
observed uniform expression of galectins in all the samples of 
invasive squamous cell carcinoma but in the preneoplastic lesions 
the expression was similar to that of normal samples except samples 
with CIN III, suggesting the malignant potential of this lesion. Here 
also, no difference was observed within the group of severe 
dysplasia so preselection by galectin expression also is not possible. 
The present study observed similar tissue binding patterns for 
galecin-3 as well as for galectin-1 and for the plant lectin with 
identical sugar specificity in the squamous epithelium of the uterine 
cervix. In squamous cell carcinomas, intraepithelial neoplasias  and 
in normal epithelium the pattern of staining was more or less same 
for both of the galectins and SGL. But in normal mucus secreting 
endocervical cells and in adenocarcinomas the expression of both of 
the galectins was confined to the apical membrane and the lumen 
whereas uniform binding of SGL with moderate intensity was 
observed all over the cytoplasm. It may be because SGL may have 
the potential to recognize intracytoplasmic galactose moieties also. 
The galectins may be much more sensitive to secreted mucin, as it 
showed expression in the lumen of the glands as well as the apical 
areas of normal endocervical cells where secreted mucin is often 
found. Neither of the galectins nor the SGL may be capable of 
recognizing the changes in glycosylation pattern in early neoplastic 
events. However, in malignancies a higher expression of the 
galectins and SGL binding were observed even though they were 
also differentiation dependent. Hence the present study found no 
application for SGL or for Galectins in predicting the malignant 
potential of CIN and suggest these lectins as markers of 
differentiation, which may have some application in pathology and 
cytology to distinguish differentiated tumors from undifferentiated 
ones.  
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